Study: Metformin helps pancreatic cancer patients with diabetes

04/5/2012 | DailyRx.com

A study in Clinical Cancer Research revealed that pancreatic cancer patients with diabetes who took metformin lived longer than those who did not take the drug. Researchers looked at 302 patients with both conditions and found that 30.1% of metformin-treated patients survived after two years, compared with 15.4% of those who did not receive metformin.

View Full Article in:

DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA